Antoine Boulanger Piette

What they invest in

[name locked] is a seasoned investor and Managing Partner at Forbion. With a background in co-founding ABN AMRO Capital Life Sciences, [name locked] has established a remarkable track record in the investment field. He specializes in life sciences investments and has been instrumental in the success of Forbion since its inception in 2006. [name locked]’s investment focus areas include building companies at an earlier stage of development, as evidenced by his involvement in portfolio companies like Azafaros, NewAmsterdam Pharma, NorthSea Therapeutics, Oxyrane, and Replimune. His partnership and collaboration style are marked by a hands-on approach, serving on the boards of various companies to drive growth and success. Forbion's recent fundraising success of €1.35 billion across two funds underscores [name locked]'s commitment to taking leading positions with investment sizes of up to €70 million per deal. Operating in the EU and NA regions, [name locked] demonstrates a keen eye for transformative bio-pharmaceutical opportunities and a proactive investment strategy that positions him as a key player in the industry.

Who works there

23 people on file: 23 with an email address, 23 with a phone number, 21 with a professional profile. Names and details are behind a free account.

No card. Each contact is charged once and stays yours.